HomeTrialNCT07021547
🔬NCT07021547Phase 1RECRUITING

A Study of LY3867070 in Healthy Participants

Study Summary

The purpose of this study is to evaluate how well LY3867070 is tolerated and what side effects may occur in healthy participants. The study drug will be administered orally. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.

Conditions
Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment196 participants
Primary Completion
Lead SponsorEli Lilly and Company
Data Retrieved2026-04-11 02:55:33.865805+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.